Deep Track Capital, LP Repare Therapeutics Inc. Transaction History

Deep Track Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.02 - $4.7 $5.38 Million - $8.37 Million	-1,780,083 Reduced 66.31%	904,261 $2.98 Million
Q1 2024 May 15, 2024	SELL	$4.53 - $8.41 $1.4 Million - $2.59 Million	-308,387 Reduced 10.3%	2,684,344 $12.6 Million
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $241,500 - $884,249	-75,000 Reduced 2.44%	2,992,731 $21.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.16 - $13.01 $2.78 Million - $4.43 Million	340,125 Added 12.47%	3,067,731 $37.1 Million
Q4 2022 Feb 14, 2023	SELL	$12.5 - $18.13 $5 Million - $7.25 Million	-400,061 Reduced 12.79%	2,727,606 $40.1 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $4.86 Million - $6.55 Million	420,005 Added 15.51%	3,127,667 $37.9 Million
Q2 2022 Aug 12, 2022	BUY	$8.45 - $14.84 $368,800 - $647,691	43,645 Added 1.64%	2,707,662 $37.9 Million
Q1 2022 May 16, 2022	BUY	$11.38 - $21.88 $6.42 Million - $12.3 Million	564,017 Added 26.86%	2,664,017 $37.9 Million
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $41.3 Million - $59 Million	2,100,000 New	2,100,000 $44.3 Million

35.3M

51K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $51.2M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.